Focus. Together. For patients & society
Ipsen (ipsen.com) earns a Brand Analyzer score of 89 out of 100, placing it in the Strong Brand tier among Healthcare brands. Among 4144 Healthcare brands analyzed, Ipsen ranks in the 98th percentile (category average 73, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 97/100, Digital Presence 100/100, Visual Identity 95/100, Messaging Clarity 95/100, Trust Foundation 97/100, AI Discoverability 82/100, Brand Authority 66/100.
Ipsen is a French global biopharmaceutical company founded in 1929, focused on innovation and specialty care to improve the lives of patients. The company concentrates its expertise and pipeline on oncology, rare diseases, and neuroscience, aiming to deliver medicines in areas of high unmet medical need. Ipsen serves patients with cancer, rare diseases, and neurological conditions, as well as healthcare providers and the broader medical community worldwide. It is led by CEO David Meek.
| Brand Name | Ipsen |
|---|---|
| Domain | ipsen.com |
| Industry | Healthcare |
| Founded | 1929 |
| Headquarters | France |
| CEO | David Meek |
| Main Competitors | Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AbbVie (84/100), BioMarin Pharmaceutical (84/100), Alexion Pharmaceuticals (87/100), Eli Lilly and Company (78/100) |
Moz Domain Authority 58/100 vs category average 37 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #124,547 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Ipsen has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, X (Twitter), YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Ipsen scores 63/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ipsen has a moderate AI-visibility profile at 63/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (52/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #124,547 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Ipsen from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Ipsen?", Claude could identify the brand as of August 2026. Ipsen is a French pharmaceutical company headquartered in Paris that focuses on specialty care, particularly in oncology, neuroscience, and rare diseases. It develops and markets treatments like Somatuline for neuroendocrine tumors and Dysport for muscle spasticity, among other t Best known for Its neuroendocrine tumor treatment Somatuline and neurotoxin Dysport used for movement disorders and aesthetics.
When asked "Best brands similar to Ipsen?", Claude would recommend Ipsen as of August 2026. It's a well established mid-to-large specialty pharma player with recognized products in oncology and neuroscience, making it a reasonable mention alongside similar specialty biopharma companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ipsen's main competitors include Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AbbVie (84/100), BioMarin Pharmaceutical (84/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Ipsen and Pfizer are competitors in Healthcare. Brand Analyzer scores Ipsen at 89/100 and Pfizer at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Ipsen include Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AbbVie (84/100), BioMarin Pharmaceutical (84/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Ipsen is a French global biopharmaceutical company founded in 1929. It focuses on innovation and specialty care, concentrating its research and development on oncology, rare diseases, and neuroscience to serve patients with high unmet medical needs.
Sources: Ipsen official site
Ipsen has moderate AI-search visibility, scoring 63/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 52, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Ipsen official site
Ipsen was founded in 1929. Ipsen operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Ipsen develops and provides biopharmaceutical medicines aimed at improving the lives of patients facing serious and rare conditions. Its work centers on oncology, rare diseases, and neuroscience, areas where treatment options are often scarce and medical need is high.
Sources: Ipsen official site
Ipsen scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Ipsen official site
Ipsen is known for its specialty biopharmaceutical focus on oncology, rare diseases, and neuroscience, positioning itself as a company dedicated to transformative innovation for patients with serious and rare conditions.
Sources: Ipsen official site
Ipsen can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Ipsen official site
Ipsen offers biopharmaceutical medicines targeting oncology, rare diseases, and neuroscience. The company's pipeline is concentrated on delivering treatments in these therapeutic areas where medical need is greatest and treatment options are limited.
Sources: Ipsen official site
Ipsen's medicines are used by patients suffering from cancer, rare diseases, and neurological conditions. The company also engages healthcare providers and the broader medical community worldwide who prescribe and administer its treatments.
Sources: Ipsen official site
Ranked closest to Ipsen: HCA Healthcare (89/100), Grifols (89/100), Kelly Services (89/100), LanguageLine Solutions (89/100).
A step up - brands to learn from: theSkimm (91/100), Replika (91/100).
Category leader: Elsevier (96/100).